Residual dizziness after manual reduction of benign paroxysmal positional vertigo
Conditions
Interventions
Experimental group:Acupuncture
Control group:Oral betahistine mesylate
Sponsors
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Patients with "residual dizziness" after surgical reduction of benign paroxysmal positional vertigo of the posterior semicircular canal; (2) No gender limit, age between 18 and 75 years old; (3) Those who can persist in this research and cooperate with treatment, and participate voluntarily.
Exclusion criteria
Exclusion criteria: (1) Those who refuse or are not suitable for manual reduction treatment, such as patients with head and neck fractures, severe heart failure, etc.; (2) Combined with other diseases that affect dizziness besides BPPV, such as central nervous system disease, cervical spondylosis, posterior circulation ischemia, vertebral-basilar artery insufficiency, other vestibular diseases, ophthalmic diseases, diabetes, migraine, and severe anxiety disorder and poorly controlled hypertension, etc.; (3) Women who are breastfeeding, pregnant or preparing to become pregnant; (4) Patients with a history of deafness, vertigo migraine, cerebrovascular disease, severe depression and other serious mental illnesses, or any organ dysfunction; (5) Those who have taken vestibular inhibitors, anti-anxiety drugs, antihistamines and other interfering drugs in the past 3 months that may affect the result determination; (6) Exclude secondary and post-traumatic BPPV.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dizziness Handicap Inventory; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analog Scale;Hamilton Rating Scale for Depression; | — |
Countries
China
Contacts
Public ContactCheng Bin
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Outcome results
None listed